{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:06:27Z","timestamp":1789985187893,"version":"4.0.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T00:00:00Z","timestamp":1443052800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T00:00:00Z","timestamp":1443052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s12098-015-1877-1","type":"journal-article","created":{"date-parts":[[2015,9,24]],"date-time":"2015-09-24T01:54:28Z","timestamp":1443059668000},"page":"248-253","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Macrophage Activation Syndrome"],"prefix":"10.1007","volume":"83","author":[{"given":"Ethan S.","family":"Sen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L. N.","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athimalaipet V.","family":"Ramanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,24]]},"reference":[{"key":"1877_CR1","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1093\/rheumatology\/40.11.1285","volume":"40","author":"JL St\u00e9phan","year":"2001","unstructured":"St\u00e9phan JL, Kon\u00e9-Paut I, Galambrun C, Mouy R, Bader-Meunier B, Prieur AM. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology. 2001;40:1285\u201392.","journal-title":"Rheumatology"},{"key":"1877_CR2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/adc.85.5.421","volume":"85","author":"S Sawhney","year":"2001","unstructured":"Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child. 2001;85:421\u20136.","journal-title":"Arch Dis Child"},{"key":"1877_CR3","first-page":"2513","volume":"30","author":"AV Ramanan","year":"2003","unstructured":"Ramanan AV, Schneider R. Macrophage activation syndrome\u2014what\u2019s in a name! J Rheumatol. 2003;30:2513\u20136.","journal-title":"J Rheumatol"},{"key":"1877_CR4","first-page":"1133","volume":"34","author":"EM Behrens","year":"2007","unstructured":"Behrens EM, Beukelman T, Paessler M, Cron RQ. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol. 2007;34:1133\u20138.","journal-title":"J Rheumatol"},{"key":"1877_CR5","first-page":"459","volume":"63","author":"MH Moradinejad","year":"2011","unstructured":"Moradinejad MH, Ziaee V. The incidence of macrophage activation syndrome in children with rheumatic disorders. Minerva Pediatr. 2011;63:459\u201366.","journal-title":"Minerva Pediatr"},{"key":"1877_CR6","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/art.22416","volume":"56","author":"J Bleesing","year":"2007","unstructured":"Bleesing J, Prada A, Siegel DM, et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum. 2007;56:965\u201371.","journal-title":"Arthritis Rheum"},{"key":"1877_CR7","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/art.24883","volume":"60","author":"A Parodi","year":"2009","unstructured":"Parodi A, Dav\u00ec S, Pringe AB, et al; Lupus Working Group of the Paedtric Rheumatology European Society. Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum. 2009;60:3388\u201399.","journal-title":"Arthritis Rheum"},{"key":"1877_CR8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.jpeds.2005.12.070","volume":"148","author":"T Avcin","year":"2006","unstructured":"Avcin T, Tse SM, Schneider R, Ngan B, Silverman ED. Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood. J Pediatr. 2006;148:683\u20136.","journal-title":"J Pediatr"},{"key":"1877_CR9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/MPH.0b013e3181dccbf4","volume":"32","author":"GA Latino","year":"2010","unstructured":"Latino GA, Manlhiot C, Yeung RS, Chahal N, McCrindle BW. Macrophage activation syndrome in the acute phase of Kawasaki disease. J Pediatr Hematol Oncol. 2010;32:527\u201331.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1877_CR10","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/pbc.22630","volume":"55","author":"G Simonini","year":"2010","unstructured":"Simonini G, Pagnini I, Innocenti L, Calabri GB, De Martino M, Cimaz R. Macrophage activation syndrome\/Hemophagocytic Lymphohistiocytosis and Kawasaki disease. Pediatr Blood Cancer. 2010;55:592.","journal-title":"Pediatr Blood Cancer"},{"key":"1877_CR11","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/S0022-3476(96)70160-9","volume":"129","author":"R Mouy","year":"1996","unstructured":"Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. J Pediatr. 1996;129:750\u20134.","journal-title":"J Pediatr"},{"key":"1877_CR12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/rheumatology\/33.5.495","volume":"33","author":"SV Davies","year":"1994","unstructured":"Davies SV, Dean JD, Wardrop CA, Jones JH. Epstein-Barr virus-associated haemophagocytic syndrome in a patient with juvenile chronic arthritis. Br J Rheumatol. 1994;33:495\u20137.","journal-title":"Br J Rheumatol"},{"key":"1877_CR13","first-page":"1014","volume":"31","author":"G Sterba","year":"2004","unstructured":"Sterba G, Rodriguez C, Sifontes S, Vigilanza P. Macrophage activation syndrome due to methotrexate in a 12-y-old boy with dermatomyositis. J Rheumatol. 2004;31:1014\u20135. author reply 5.","journal-title":"J Rheumatol"},{"key":"1877_CR14","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10067-012-1998-0","volume":"31","author":"CI Lin","year":"2012","unstructured":"Lin CI, Yu HH, Lee JH, et al. Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases. Clin Rheumatol. 2012;31:1223\u201330.","journal-title":"Clin Rheumatol"},{"key":"1877_CR15","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/ard.44.5.341","volume":"44","author":"DC Heaton","year":"1985","unstructured":"Heaton DC, Moller PW. Still\u2019s disease associated with Coxsackie infection and haemophagocytic syndrome. Ann Rheum Dis. 1985;44:341\u20134.","journal-title":"Ann Rheum Dis"},{"key":"1877_CR16","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s12098-014-1425-4","volume":"81","author":"S Raju","year":"2014","unstructured":"Raju S, Kalyanaraman S, Swaminathan K, Nisha A, Praisid S. Hemophagocytic lymphohistiocytosis syndrome in Dengue hemorrhagic fever. Indian J Pediatr. 2014;81:1381\u20133.","journal-title":"Indian J Pediatr"},{"key":"1877_CR17","first-page":"4","volume":"2","author":"AJ van der Ven","year":"2015","unstructured":"van der Ven AJ, Netea MG, van der Meer JW, de Mast Q. Ebola virus disease has features of hemophagocytic lymphohistiocytosis syndrome. Front Med (Lausanne). 2015;2:4.","journal-title":"Front Med (Lausanne)"},{"key":"1877_CR18","doi-asserted-by":"publisher","first-page":"161","DOI":"10.5644\/ama2006-124.49","volume":"41","author":"S Rajagopala","year":"2012","unstructured":"Rajagopala S, Singh N. Diagnosing and treating hemophagocytic lymphohistiocytosis in the tropics: systematic review from the Indian subcontinent. Acta Med Acad. 2012;41:161\u201374.","journal-title":"Acta Med Acad"},{"key":"1877_CR19","first-page":"865","volume":"28","author":"A Ravelli","year":"2001","unstructured":"Ravelli A, Caria MC, Buratti S, Malattia C, Temporini F, Martini A. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol. 2001;28:865\u20137.","journal-title":"J Rheumatol"},{"key":"1877_CR20","first-page":"401","volume":"30","author":"AV Ramanan","year":"2003","unstructured":"Ramanan AV, Schneider R. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis. J Rheumatol. 2003;30:401\u20133.","journal-title":"J Rheumatol"},{"key":"1877_CR21","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/med\/9780199642489.003.0168","volume-title":"Oxford textbook of rheumatology","author":"A Grom","year":"2013","unstructured":"Grom A, Ramanan A. Macrophage activation syndrome. In: Watts R, Conaghan P, Denton C, Foster H, Isaacs J, M\u00fcller-Ladner U, editors. Oxford textbook of rheumatology. 4th ed. New York: Oxford University Press; 2013. p. 1442\u20136.","edition":"4"},{"key":"1877_CR22","first-page":"2068","volume":"31","author":"AV Ramanan","year":"2004","unstructured":"Ramanan AV, Rosenblum ND, Feldman BM, Laxer RM, Schneider R. Favorable outcome in patients with renal involvement complicating macrophage activation syndrome in systemic onset juvenile rheumatoid arthritis. J Rheumatol. 2004;31:2068\u201370.","journal-title":"J Rheumatol"},{"key":"1877_CR23","first-page":"2120","volume":"28","author":"S Prahalad","year":"2001","unstructured":"Prahalad S, Bove KE, Dickens D, Lovell DJ, Grom AA. Etanercept in the treatment of macrophage activation syndrome. J Rheumatol. 2001;28:2120\u20134.","journal-title":"J Rheumatol"},{"key":"1877_CR24","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/pbc.21423","volume":"50","author":"CE Allen","year":"2008","unstructured":"Allen CE, Yu X, Kozinetz CA, McClain KL. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008;50:1227\u201335.","journal-title":"Pediatr Blood Cancer"},{"key":"1877_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124\u201331.","journal-title":"Pediatr Blood Cancer"},{"key":"1877_CR26","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1002\/art.38769","volume":"66","author":"S Dav\u00ec","year":"2014","unstructured":"Dav\u00ec S, Minoia F, Pistorio A, et al. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Arthritis Rheum. 2014;66:2871\u201380.","journal-title":"Arthritis Rheum"},{"key":"1877_CR27","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jpeds.2004.12.016","volume":"146","author":"A Ravelli","year":"2005","unstructured":"Ravelli A, Magni-Manzoni S, Pistorio A, et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr. 2005;146:598\u2013604.","journal-title":"J Pediatr"},{"key":"1877_CR28","doi-asserted-by":"publisher","first-page":"764","DOI":"10.3899\/jrheum.100996","volume":"38","author":"S Dav\u00ec","year":"2011","unstructured":"Dav\u00ec S, Consolaro A, Guseinova D, et al. An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis. J Rheumatol. 2011;38:764\u20138.","journal-title":"J Rheumatol"},{"key":"1877_CR29","doi-asserted-by":"publisher","first-page":"O1","DOI":"10.1186\/1546-0096-12-S1-O1","volume":"12","author":"F Minoia","year":"2014","unstructured":"Minoia F, Davi S, Bovis F, et al. Development of new classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Pediatr Rheumatol. 2014;12:O1.","journal-title":"Pediatr Rheumatol"},{"key":"1877_CR30","doi-asserted-by":"crossref","unstructured":"Minoia F, Dav\u00ec S, Horne A, et al. Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients. Arthritis Rheum. 2014;66:3160\u20139.","DOI":"10.1002\/art.38802"},{"key":"1877_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.berh.2014.03.002","volume":"28","author":"GS Schulert","year":"2014","unstructured":"Schulert GS, Grom AA. Macrophage activation syndrome and cytokine-directed therapies. Best Pract Res Clin Rheumatol. 2014;28:277\u201392.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1877_CR32","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0022-3476(96)70408-0","volume":"128","author":"A Ravelli","year":"1996","unstructured":"Ravelli A, De Benedetti F, Viola S, Martini A. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr. 1996;128:275\u20138.","journal-title":"J Pediatr"},{"key":"1877_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/01.rhu.0000081259.61370.eb","volume":"9","author":"AG Tristano","year":"2003","unstructured":"Tristano AG, Casanova-Escalona L, Torres A, Rodr\u00edguez MA. Macrophage activation syndrome in a patient with systemic onset rheumatoid arthritis: rescue with intravenous immunoglobulin therapy. J Clin Rheumatol. 2003;9:253\u20138.","journal-title":"J Clin Rheumatol"},{"key":"1877_CR34","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/gene.2012.3","volume":"13","author":"A Ravelli","year":"2012","unstructured":"Ravelli A, Grom AA, Behrens EM, Cron RQ. Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment. Genes Immun. 2012;13:289\u201398.","journal-title":"Genes Immun"},{"key":"1877_CR35","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.clim.2009.02.005","volume":"132","author":"A Coca","year":"2009","unstructured":"Coca A, Bundy KW, Marston B, Huggins J, Looney RJ. Macrophage activation syndrome: serological markers and treatment with anti-thymocyte globulin. Clin Immunol. 2009;132:10\u20138.","journal-title":"Clin Immunol"},{"key":"1877_CR36","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/ncprheum0919","volume":"4","author":"A Kelly","year":"2008","unstructured":"Kelly A, Ramanan AV. A case of macrophage activation syndrome successfully treated with anakinra. Nat Clin Pract Rheumatol. 2008;4:615\u201320.","journal-title":"Nat Clin Pract Rheumatol"},{"key":"1877_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/rheumatology\/keq218","volume":"50","author":"PM Miettunen","year":"2011","unstructured":"Miettunen PM, Narendran A, Jayanthan A, Behrens EM, Cron RQ. Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients. Rheumatology. 2011;50:417\u20139.","journal-title":"Rheumatology"},{"key":"1877_CR38","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/art.30128","volume":"63","author":"PA Nigrovic","year":"2011","unstructured":"Nigrovic PA, Mannion M, Prince FH, et al. Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series. Arthritis Rheum. 2011;63:545\u201355.","journal-title":"Arthritis Rheum"},{"key":"1877_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/RHU.0b013e3181a4f459","volume":"15","author":"A Zeft","year":"2009","unstructured":"Zeft A, Hollister R, LaFleur B, et al. Anakinra for systemic juvenile arthritis: the rocky mountain experience. J Clin Rheumatol. 2009;15:161\u20134.","journal-title":"J Clin Rheumatol"},{"key":"1877_CR40","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMoa1205099","volume":"367","author":"N Ruperto","year":"2012","unstructured":"Ruperto N, Brunner HI, Quartier P, et al. Two randomized trials of canakinumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367:2396\u2013406.","journal-title":"N Engl J Med"},{"key":"1877_CR41","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1112802","volume":"367","author":"F De Benedetti","year":"2012","unstructured":"De Benedetti F, Brunner HI, Ruperto N, et al. Randomized trial of tocilizumab in systemic juvenile idiopathic arthritis. N Engl J Med. 2012;367:2385\u201395.","journal-title":"N Engl J Med"},{"key":"1877_CR42","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/S0140-6736(08)60454-7","volume":"371","author":"S Yokota","year":"2008","unstructured":"Yokota S, Imagawa T, Mori M, et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial. Lancet. 2008;371:998\u20131006.","journal-title":"Lancet"},{"key":"1877_CR43","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1093\/rheumatology\/keu019","volume":"53","author":"E Savage","year":"2014","unstructured":"Savage E, Wazir T, Drake M, Cuthbert R, Wright G. Fulminant myocarditis and macrophage activation syndrome secondary to adult-onset Still\u2019s disease successfully treated with tocilizumab. Rheumatology. 2014;53:1352\u20133.","journal-title":"Rheumatology"},{"key":"1877_CR44","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.cyto.2012.02.006","volume":"58","author":"M Shimizu","year":"2012","unstructured":"Shimizu M, Nakagishi Y, Kasai K, et al. Tocilizumab masks the clinical symptoms of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome: the diagnostic significance of interleukin-18 and interleukin-6. Cytokine. 2012;58:287\u201394.","journal-title":"Cytokine"},{"key":"1877_CR45","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1097\/MPH.0b013e3180f61be3","volume":"29","author":"NJ Balamuth","year":"2007","unstructured":"Balamuth NJ, Nichols KE, Paessler M, Teachey DT. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol. 2007;29:569\u201373.","journal-title":"J Pediatr Hematol Oncol"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-015-1877-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-015-1877-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-015-1877-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-015-1877-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:04:21Z","timestamp":1744149861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-015-1877-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,24]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["1877"],"URL":"https:\/\/doi.org\/10.1007\/s12098-015-1877-1","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,24]]},"assertion":[{"value":"22 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}